Is sell-side coverage objective?
Hi, I'm on the VC side with little exposure to public. Heard a public markets investor tell me they aggregate coverage analysts and use that to give them direction.
Question for those of:
1. How objective is your coverage? (my understanding coverage exists for marketing and not a critical analysis)
2. How do you decide on which companies to cover? (is this purely driven by front-office requirements, or is there an overarching strategy to have sufficient coverage within a given market?)